Abstract
Objectives:
Systems biology is a novel subject in the field of life science that aims at a systems’ level understanding of biological systems. Because of the significant progress in high-throughput technologies and molecular biology, systems biology occupies an important place in research during the post-genome era.
Methods:
The characteristics of systems biology and its applicability to traditional medicine research have been discussed from three points of view: data and databases, network analysis and inference, and modeling and systems prediction.
Results:
The existing databases are mostly associated with medicinal herbs and their activities, but new databases reflecting clinical situations and platforms to extract, visualize and analyze data easily need to be constructed. Network pharmacology is a key element of systems biology, so addressing the multi-component, multi-target aspect of pharmacology is important. Studies of network pharmacology highlight the drug target network and network target. Mathematical modeling and simulation are just in their infancy, but mathematical modeling of dynamic biological processes is a central aspect of systems biology. Computational simulations allow structured systems and their functional properties to be understood and the effects of herbal medicines in clinical situations to be predicted.
Conclusion:
Systems biology based on a holistic approach is a pivotal research methodology for understanding the mechanisms of traditional medicine. If systems biology is to be incorporated into traditional medicine, computational technologies and holistic insights need to be integrated.
Keywords: computational modeling, multi-target drugs, network pharmacology, systems biology, traditional medicine
1. Introduction
At the turn of the 20th century, a remarkable development, which cannot be compared with anything in the previous century, has emerged in the field of biology, partly because of the completion of the Human Genome Project which identified three billion chromosomes of human deoxyribonucleic acid (DNA). Expectations were that humans might be able to learn the secrets and to understand the mechanisms of life and death as a result of the knowledge gained from the project. A sequence or a function of a gene, however, could not explain everything about human beings; therefore, interest in the interactions of genes and proteins, the physiological functions, and the complex networks in living systems has increased [1].
Recently, the number of attempts to interpret diverse information on complex biological phenomena at the systems level has increased because of the development of high-throughput technologies and data analysis methods for processing large amounts of data [2]. Omics technologies such as genomics, proteomics, metabolomics and transcriptomics have made it possible to obtain large amounts of information and to understand biological phenomena as a whole. Computational studies such as bioinformatics, data mining, machine learning, and so on have enabled us to understand and predict interactions and patterns of biological systems [1].
These recent developments in systematic understanding biological phenomena (human physiological functions) can be incorporated into systems biology. The emergence of systems biology is partly because of the availability of huge amounts of quantitative data because of advancements in high-throughput technologies and partly because of the development of computational methodologies. Systems biology is a quite new term in the field of life sciences, and it focuses on not the living thing itself but the emerging properties of the whole network by looking at the interactions of the essential factors of organisms [3]. Systems biology, therefore, has integrative and multi-scale characteristics.
Traditional medicine has mainly been used by Asian countries such as Korea, China, and Japan for thousands of years to maintain the health of their populations. The use of traditional medicine in the world has markedly increased over the last decades. Traditional medicine is based on clinical experiences acquired over a long time and is guided by East Asian traditional philosophy such as Yin-yang and five phases which underline the balance of the functional system. Traditional medicine also adheres to a personalized and holistic approach to describe health and disease [4].
The viewpoint of systems biology is consistent with the holistic perspective of traditional medicine. The concepts of systems biology and some aspects of traditional medicine are quite similar. For example, whilst systems biology is associated with the integration of the part into the whole, holistic approaches of traditional medicine consider the body as a whole [5]. Therefore, interest in a systems biology approach investigating traditional medicine is greatly increasing, with the main focus being on drug discovery and development. In other words, systems biology is becoming a cutting edge research field in current drug discovery and development.
In this study, therefore, recent advances in systems biology and its applicability to traditional medicine research are investigated. The systems biology approach is discussed from three points of view: data and databases, network analysis and inference, and modeling and systems prediction. Also, the application of systems-biology methodologies to explain the mechanism of herbal medicine is investigated.
2. Data and Databases
These days, the ability to differentiate what information is valuable is becoming more important because of the flood of data and documents. In particular, as the development of high-throughput technologies has made possible the production of large amounts of data in the field of life sciences, the interpretation of those data has become more important [6, 7]. Accordingly, the demand for new and efficient data mining methods has greatly increased. Data mining aims at extracting structured information or discovering novel knowledge from a massive amount of data. For this reason, one of the most important prerequisites for data mining and systems biology is data availability. If the amount of data is not sufficient, data research should not be undertaken.
Data mining methods can be conducted by using various kinds of information obtained from sources such as bibliographic literature, experimental data, clinical data, etc. In particular, the bibliographic literature on research conducted in the field of basic Korean medical sciences should be included in data mining by using original texts as data sources. In recent research, more complex and elaborate analyses have become available due to the use of as much data as possible, which is due to the development of computational technologies. Because structured databases are essential to productive data mining, many researchers have focused on the construction of databases for traditional medicine. These efforts have resulted in the constructions of various databases such as the traditional Chinese medical literature analysis and retrieval system (TCMLARS) [8], the Korean traditional knowledge portal [9], and the knowledge of Oriental medicine web service [10], all of which are mainly related to original texts and research papers in the field of traditional medicine. Moreover, sources of traditional medicine information for proper data mining and systems biology have been introduced recently. Especially, information on herbal medicines, including herbal prescriptions, individual herbs, and compounds, could be a very good source for systems biology research because such information can provide increased knowledge for understanding the underlying mechanisms of herbal medicines and for developing drugs. A list of several traditional medicine databases for systems biology research is presented in (Table 1).
Table. 1. Traditional medicine databases.
Database | Description | URL | Reference |
---|---|---|---|
TCM-ID | 1,197 prescriptions, 1,104 herbs, 9,862 ingredients, 12,117 compounds, and 4,111 diseases | http://bidd.nus.edu.sg/group/TCMsite/Default.aspx | [11] |
TCMID | 46,914 prescriptions, 8,159 herbs, 25,210 ingredients, 6,826 drugs, 17,521 related targets, and 3,791 diseases | http://www.megabionet.org/tcmid/ | [12] |
TCM Database@Taiwan | 352 herbs, and 37,170 compounds | http://tcm.cmu.edu.tw/ | [13] |
TCMGeneDit | Associated information between TCMs and genes, diseases, effects and ingredients | http://tcm.lifescience.ntu.edu.tw | [40] |
TCMSP | 499 herbs, 29,384 ingredients, 3,311 targets, and 837 associated diseases | http://sm.nwsuaf.edu.cn/lsp/tcmsp.php | [14] |
TM-MC | 536 medicinal materials, 14,492 compounds, and 24,154 links betweenmedicinal materials and compounds | http://informatics.kiom.re.kr/compound/ | [16] |
CancerHSP | 2,349 anticancer herbs, 3,575 anticancer ingredients and their molecular structures, and ADME parameters | http://lsp.nwsuaf.edu.cn/CancerHSP.php | [17] |
CEMTDD | 621 herbs, 4,060 compounds, 2,163 targets, and 210 diseases | http://www.cemtdd.com/index.html | [15] |
TCM-ID, traditional Chinese medicine information database; TCMID, traditional Chinese medicine integrated database; TCMSP, traditional Chinese medicine systems pharmacology database and analysis platform; TM-MC, database of medicinal materials and chemical compounds in northeast Asian traditional medicine; CancerHSP, anti-cancer herbs database of systems pharmacology; ADME, absorption, distribution, metabolism, and excretion; CEMTDD, Chinese ethnic minority traditional drugs database.
The traditional Chinese medicine-information database (TCM-ID) was developed as a convenient and integrated source for information on all aspects of traditional medicine. TCM-ID, containing 1,197 prescriptions covering 1,104 herbs, 9,862 ingredients and 4,111 diseases, provides a 3D structure of ingredients and is searchable by prescription, medicinal herb or ingredient name [11]. The traditional Chinese medicines integrated database (TCMID), the largest database for traditional medicine, comprises six data fields: 46,914 prescriptions, 8,159 herbs, 25,210 ingredients, 17,521 related targets, and information associated with modern medicines including information on drugs (6,286) and diseases (3,791) [12]. It provides a virtual display of connections between herbs and herbal ingredients and their targets by means of network-display tools. TCM Database@Taiwan has been developed to provide a free 3D small molecular structure database for traditional medicine [13]. The traditional Chinese medicine systems pharmacology (TCMSP) database and analysis platform plays a role not only as a data repository but also as a platform for the visualization and analysis of traditional medicine on a network level [14]. The Chinese ethnic minority traditional drugs database (CEMTDD), containing 621 herbs, 4,060 compounds, 2,163 targets, and 210 diseases, displays networks for relations between herbs and diseases as well as between active compounds and active targets [15]. The database of medicinal materials and chemical compounds in northeast Asian traditional medicine (TMMC), the most recently developed database, has tried to overcome the shortcomings of earlier databases, such as redundancy of herbs in a system, and contains medicinal materials from Korean, Chinese and Japanese pharmacopoeias [16]. The anticancer herbs database of systems pharmacology (CancerHSP) is a specialized database on anticancer herbs. This database, which contains anticancer activities from 492 cancer cell lines, helps to define the molecular mechanisms of anticancer activities [17].
Data availability is the first consideration of data mining and systems biology because the more data that exist; the more the information that can be obtained. The recently- developed traditional medicine databases contain several categories, such as prescriptions, herbs, compounds, targets and diseases. Databases are evolving these days. Whilst some databases provide herb-related information, other databases provide analysis tools to evaluate the relations between information [14]. Recently, specific disease- related databases have been developed, and these specialized databases offer more detailed information for understanding the associations between disease- and treatment-related factors [17].
Nevertheless, existing databases have several drawbacks. First, most databases do not state where their information came from, which will detract from the reliability of the databases. Second, some databases include a large amount of information but they do not discriminate between synonyms of the same medicinal herb. Last, language barriers exist because some databases do not provide multi-language platforms. Nevertheless, recent trends are amazing in the ways that researchers have overcome the shortcomings of databases and have generated many studies based on databases. Overall, databases need to be established to allow systems biology to be defined and evaluated.
As traditional medicine has been practiced for thousands of years because of its clinical efficacy, new treatment methods often arise from clinical situations. Moreover, traditional medicine has recently been shown to be very effective in treating various chronic diseases such as cancer, rheumatoid arthritis, leukemia, and migraine. Therefore, identifying medical knowledge from clinical data and collating quantitative biomarkers could become a significant step to bridge the gap between clinical practice and traditional medical theory [18]. Also, platforms to extract, visualize and analyze multi-dimensional data easily must be built.
3. Network analysis and Inference
The most active research field in systems biology-based traditional medicine studies is the network analysis of the relations among herbal prescriptions, individual herbs, compounds, targets, and diseases. Systems biology, by using computational methods on high-throughput experimental data, can offer a fast way to achieve the goal of identifying the networks by which components interact to carry out their regulatory functions. The major technologies here have become popular tools for understanding the network relations between key factors and for discovering drugs. The recent application of forefront technologies using medicinal herbs and formulae has provided an in depth understanding of their targets and ingredients, which has facilitated an understanding of their mechanisms and actions. However, because herbal formulae and herbs contain a large number of ingredients and their synergistic and antagonistic effects cannot be easily classified, the detailed mechanisms of medicinal herbs and formulae still remain unclear. Although complex ingredients and complex actions of herbs/herbal prescriptions are unique characteristics, they are also ambiguous points that hinder our understanding of their actions. However, recent developments of computational methodologies have allowed the analyses of huge amounts of data simultaneously, and these data mining technologies hold the limelight as a novel approach to the discovery of new drugs.
Network pharmacology, a key technology of systems biology, determines how various ingredients interact by constructing drug-target-disease networks and analyzing them. It has attracted much attention by researching the molecular mechanisms of herbal formulae and herbs with complicated targets and diseases. The rise of network pharmacology accentuates a paradigm shift from a “single- component, single-target” strategy to a “multi-component, multi-target” feature. Traditional medicine takes an initiating role in the “multi-component, multi-target” therapies because hundreds of different components in a prescription can cure a disease or even one herb shows dynamic effects because of its multiple actions. Therefore, explicating the underlying mechanism of a herbal medicine is very difficult because of its complex composition, though its efficacy is not in doubt.
Many network-based computational studies have been conducted to find effective components and to detect the mechanisms of the actions of herbal prescriptions/herbs against many diseases/targets (Table 2). Since the mid- 2000s, interdisciplinary research between network pharmacology and herbs/herbal prescriptions has been undertaken mainly by the Li Shao group [19-22]. That group proposed “network target” theory, which is a disease-specific bio-molecular network, as a core in the “Herb network (Herbal formula) ─ Biological network (Network target) ─ Phenotype network (Disease)” [19]. The close relations among those three networks make it possible to explain the holistic approach of traditional medicine and to provide a new paradigm for drug development.
Table. 2. Selected network pharmacology studies of traditional medicine.
Herb/Herbal ingredients/Herbal prescriptions | Related diseases/Symptoms/ Target | Year | Reference |
---|---|---|---|
Qing-Luo-Yin (Hot-Cooling herbal formula) Wen-Luo-Yin (Cold-Warming herbal formula) |
Cold- and Hot-syndromerelated rheumatoid arthritis |
2007 | [21] |
Ganoderic acid D (from Ganoderma lucidum) |
Cancer | 2008 | [23] |
Rhizoma chuanxiong herb network from 3,865 collaterals-related herbal formulae |
Angiogenesis disorder | 2010 | [20] |
676 compounds | Type II diabetes mellitus | 2011 | [24] |
Yishen Juanbi tablet (containing the water extracts of seven herbs) |
Rheumatoid arthritis | 2012 | [28] |
Ligusticum chuanxiong Hort., Dalbergia odorifera T. Chen., and Corydalis yanhusuo WT Wang |
Cardiovascular disease | 2012 | [25] |
Rhein (from rhubarb) | Target prediction | 2013 | [41] |
Si-Wu-Tang | Target prediction | 2013 | [42] |
Licorice (the root of three Glycyrrhiza species) |
Target prediction | 2013 | [26] |
Qing-Luo-Yin | Rheumatoid arthritis | 2014 | [22] |
Xiao-Chaihu decoction Da-Chaihu decoction |
Target prediction using addition and subtraction theory |
2014 | [43] |
Dan-Shen decoction | Coronary heart disease | 2014 | [29] |
Ten herbs (Salvia miltiorrhizae, Ginkgo biloba, Ephedrae herba and so on) |
Stroke | 2014 | [27] |
Folium eriobotryae | Inflammation | 2015 | [44] |
Zhi-Zi-Da-Huang decoction | Alcoholic liver disease | 2015 | [45] |
Tianshu formula | Migraine | 2015 | [46] |
The domain of network pharmacology research embraces herbal prescriptions, individual herbs, and compounds. The related diseases are also very broad, ranging from immunological disorders such as rheumatoid arthritis to chronic diseases such as diabetes mellitus to other diseases such as cancer, alcohol-related liver diseases, and migraine headaches. Most explorations have focused on drug (herbal prescriptions, herbs, compounds, or ingredients) ─ target networks [23-26], but some have focused on the herb network in herbal prescriptions [20] and the target signaling pathway network [27]. Some studies have spotlighted pattern identification following a disease and have developed a disease-pattern-target network to understand the mechanisms of herbal medicines in treating diseases [21, 28, 29]. The information gained from the comparisons among these networks may provide new knowledge to understand mechanisms, detect new network targets, and propose new combinations of herb/compounds. Overall, for the study of network pharmacology, traditional medicine theories, omics technologies and bioinformatics technologies, including computational mining methods and machine learning methods, are combined to interpret the mechanisms of herbs/prescriptions-target-diseases effectively.
4. Modeling and Systems prediction
The use of mathematical modelling and analysis and prediction of systems has a long history since the first mathematical cardiac model developed in the 1960s [30]. For several decades since then, various kinds of mathematical models have been developed to verify hypotheses and predict systems. A model is a set of structured assertions that state the interactions among entities of a system. The entities in a model can be various, such as the specific biological elements or the specific characteristics of a system. In addition, the interactions can be due to various processes in a system, such as molecular reactions or the movement of a molecule. Changes of entities over time and space can be inferred by using a mathematical model. In other words, computational models allow us to understand a structured system and its functional properties at the systems level [6].
The in silico simulations in mathematical disease models are applicable for cost-effective assessments of drug efficacy and safety, which has made modeling methodologies more popular. Since the completion of the genome project and the development of high-throughput technologies for mass-produced biological data, mathematical modeling has become an important tool for drug development [31, 32]. Advances in systems biology by using computational technologies are expected to generate more tools to mine information for new theories in drug discovery.
Only a few simulation studies have demonstrated mathematical modeling with herbs and herbal prescriptions (Table 3). Paeoniflorin and paeonol extracted from the paeoniaceae family were shown in in vivo tests to block several ion channel flows in cardiac myocytes [33, 34], but no data suggest that those actions can assure cardiaoprotective effects. When the effects of paeoniflorin and paeonol are simulated in the mathematical cardiac model, both compounds allow the recovery of the cardiac ventricular action potential from early after-depolarizations (EADs) [35, 36]. Interestingly, Shen-Song-Yang-Xin (SSYX), a Chinese herbal formula including nine herbs, has been shown to block multiple ion channels such as INa, ICaL, Ito, IKs, and IK1 and to change the duration of the action potential. When SSYX treatment was simulated by using an EADs-induced cardiac myocyte model, SSYX fully reversed the effect on repolarization, showing that SSYX might have cardioprotective effects [37]. These approaches could be the best examples for modeling multi-component, multi-action therapies using herbal prescriptions.
Table. 3. Modeling prediction studies of traditional medicine.
Herb/Herbal ingredients/Herbal prescriptions | Related diseases/Symptoms/Targets | Year | Reference |
---|---|---|---|
Paeoniflorin | Arrhythmia/Cardiac ion channels | 2013 | [35] |
Paeonol | Arrhythmia/Cardiac ion channels |
2015 |
[36] |
SSYX (containing nine medicinal herbs) | Arrhythmia/Cardiac ion channels | 2013 | [37] |
SSYX, Shen-Song-Yang-Xin.
The paradigm shift from a “single-component, single-target” strategy to a “multi-component, multi-target” strategy can be applied in mathematical modelling because a simulation shows the comprehensive actions of herbs and herbal formulae at the systems level. As stated, experimental data can be translated into how it will work in a system and vice versa. Simulation studies also play an important role in connecting links between in vivo/in vitro experiments and clinical studies. For example, in vivo studies of SSYX only showed that it inhibited cardiac ion channel flows, but simulation studies showed that it might have cardiaoprotective effects. Thus, clearly, computational simulations are innovative methods for developing drug in terms of cost and time savings.
However, a more widespread integration of modeling and experimental programs needs to be developed to understand the biological function of a whole system. Therefore, the virtual physiological human (VPH) project was initiated in 2006. The VPH is intended to provide a unifying framework to facilitate integration and prediction, eventually creating the human body as a single complex system in silico. In the future, the VPH is expected to lead to a better healthcare system with a more holistic approach to medicine and a preventative approach to diseases [38, 39].
Although simulation studies using traditional medicine are just an opening stage, their applicability is growing. For future studies, developing a systematic computational model to predict the complex effects of herbal medicines via computational disease models based on traditional medicine would be a challenge. Such an approach would help us to understand the complicated actions of herbal medicines at the systems level.
5. Future prospects
Systems biology has been applied in research on traditional medicine, especially research on herbal medicines. The efficacy of a herbal medicine is considered to be due to the combined effects of its various ingredients, the so called multi-component effect. Therefore, a systems biology approach based on a holistic viewpoint may provide a way to understand the mechanisms of herbal medicines, which is the reason the systems biology approach is highlighted as a meaningful drug development method [31].
The systems biology approach to traditional medicine has special features that are different from those of previous research approaches originating from reductionist’s aspects [47]. However, not many meaningful outcomes are connected to or reflected in clinical situations partly because the linear and reductive perspectives used in modern scientific research are not sufficient to reflect the holistic perspectives of traditional medicine. Accordingly, the use of a systems biology approach should allow progress to be made in understanding the mechanisms of traditional medicine, though shortcomings, such as the lack of databases and computational models, still exist. Therefore, much work still needs to be done if the holistic perspectives of traditional medicine and the multiple actions of herbal medicines are to be understood through the mathematical tools provided by systems biology.
In conclusion, interactions between systems biology and traditional medicine are currently taking place. The applicability of systems biology to traditional medicine depends on establishing the infrastructure to collaborate different disciplines, finding better network pharmacology methods and mathematical models, and integrating computational technologies into holistic perspectives. Clearly, these new mathematical research methodologies will be useful and valuable tools for closing the gap between basic and clinical sciences and for understanding the link between Western and traditional medicine.
Acknowledgments
This work was supported by the Sangji University Research Fund, 2012 and the National Research Foundation of Korea Grant funded by the Korean Government (NRF- 2012-013-2012S1A2A1A01031775).
Footnotes
Conflict of interest The authors declare that there are no conflict of interest.
ORCID Soojin Lee. http://orcid.org/0000-0002-5362-1199.
References
- 1.Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56–68. doi: 10.1038/nrg2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Calvete JJ, Sanz L, Pla D, Lomonte B, Gutierrez JM. Omics meets biology: application to the design and preclinical assessment of antivenoms. Toxins. 2014;6(12):3388–3405. doi: 10.3390/toxins6123388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kitano H. Looking beyond the details: a rise in system- oriented approaches in genetics and molecular biology. Curr Genet. 2002;41(1):1–10. doi: 10.1007/s00294-002-0285-z. [DOI] [PubMed] [Google Scholar]
- 4.Normile D. Asian medicine. the new face of traditional Chinese medicine. Science. 2003;299(5604):188–190. doi: 10.1126/science.299.5604.188. [DOI] [PubMed] [Google Scholar]
- 5.Noble D. Could there be a synthesis between Western and Oriental medicine, and with sasang constitutional medicine in particular? Evid Based Complement Alternat Med. 2009;6(S1):5–10. doi: 10.1093/ecam/nep101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cassman M, Arkin A, Doyle F, Katagiri F, Lauffenburger D, Stokes C. Systems biology - international research and development. Netherlands Springer; Dordrecht: 2007. pp. 15, 47-49. [Google Scholar]
- 7.Zhou X, Peng Y, Liu B. Text mining for traditional Chinese medical knowledge discovery: a survey. J Biomed Inform. 2010;43(4):650–660. doi: 10.1016/j.jbi.2010.01.002. [DOI] [PubMed] [Google Scholar]
- 8.Fan W. The traditional Chinese medical literature analysis and retrieval system (TCMLARS) and its application. Inspel. 2001;35(3):147–156. [Google Scholar]
- 9.Korean traditional knowledge portal [Internet] Korean Intellectual Property Office; Seoul: 2011. [[cited 2015 Aug 10]]. Available from: http://www.koreantk.com/ [Google Scholar]
- 10.Knowledge of Oriental medicine web service [Internet] KIOM; Daejeon: 2007. [[cited 2015 Aug 10]]. Available from: http://jisik.kiom.re.kr/ [Google Scholar]
- 11.Wang JF, Zhou H, Han LY, Chen X, Chen YZ, Cao ZW. Traditional Chinese medicine information database. Clin Pharmacol Ther. 2005;78(1):92–93. doi: 10.1016/j.clpt.2005.03.010. [DOI] [PubMed] [Google Scholar]
- 12.Xue R, Fang Z, Zhang M, Yi Z, Wen C, Shi T. TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res. 2013;41:1089–1095. doi: 10.1093/nar/gks1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chen CY. TCM database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS One. 2011;6(1):e15939. doi: 10.1371/journal.pone.0015939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ru J, Li P, Wang J, Zhou W, Li B, Huang C et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6(13):1–6. doi: 10.1186/1758-2946-6-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Huang J, Wang JH. CEMTDD: Chinese ethnic minority traditional drug database. Apoptosis. 2014;19(9):1419–1420. doi: 10.1007/s10495-014-1011-2. [DOI] [PubMed] [Google Scholar]
- 16.Kim SK, Nam SJ, Jang HC, Kim AN, Lee JJ. TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine. BMC Complement Altern Med. 2015;15(218):1–8. doi: 10.1186/s12906-015-0758-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tao W, Li B, Gao S, Bai Y, Shar PA, Zhang W et al. CancerHSP: anticancer herbs database of systems pharmacology. Sci Rep. 2015;5(11481):1–6. doi: 10.1038/srep11481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Zhou X, Chen S, Liu B, Zhang R, Wang Y, Li P et al. Development of traditional Chinese medicine clinical data warehouse for medical knowledge discovery and decision support. Artif Intell Med. 2010;48(2-3):139–152. doi: 10.1016/j.artmed.2009.07.012. [DOI] [PubMed] [Google Scholar]
- 19.Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11(S2):110–120. doi: 10.3724/SP.J.1009.2013.00110. [DOI] [PubMed] [Google Scholar]
- 20.Li S, Zhang B, Jiang D, Wei Y, Zhang N. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics. 2010;11(S11):1–12. doi: 10.1186/1471-2105-11-S11-S6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, Wang YY. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol. 2007;1(1):51–60. doi: 10.1049/iet-syb:20060032. [DOI] [PubMed] [Google Scholar]
- 22.Zhang B, Wang X, Li S. An integrative platform of TCM network pharmacology and its application on a herbal formula, qing-luo-yin. Evid Based Complement Alternat Med. 2013;2013:ID456747. doi: 10.1155/2013/456747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Yue QX, Cao ZW, Guan SH, Liu XH, Tao L, Wu WY et al. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics. 2008;7(5):949–961. doi: 10.1074/mcp.M700259-MCP200. [DOI] [PubMed] [Google Scholar]
- 24.Gu J, Zhang H, Chen L, Xu S, Yuan G, Xu X. Drug-target network and polypharmacology studies of a traditional Chinese medicine for type II diabetes mellitus. Comput Biol Chem. 2011;35(5):293–297. doi: 10.1016/j.compbiolchem.2011.07.003. [DOI] [PubMed] [Google Scholar]
- 25.Wang X, Xu X, Tao W, Li Y, Wang Y, Yang L. A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease. Evid Based Complement Alternat Med. 2012;2012:ID519031. doi: 10.1155/2012/519031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Liu H, Wang J, Zhou W, Wang Y, Yang L. Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. J Ethnopharmacol. 2013;146(3):773–793. doi: 10.1016/j.jep.2013.02.004. [DOI] [PubMed] [Google Scholar]
- 27.Zhang J, Li Y, Chen X, Pan Y, Zhang S, Wang Y. Systems pharmacology dissection of multi-scale mechanisms of action for herbal medicines in stroke treatment and prevention. PLoS One. 2014;9(8):e102506. doi: 10.1371/journal.pone.0102506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Jiang M, Lu C, Chen G, Xiao C, Zha Q, Niu X et al. Understanding the molecular mechanism of interventions in treating rheumatoid arthritis patients with corresponding traditional Chinese medicine patterns based on bioinformatics approach. Evid Based Complement Alternat Med. 2012;2012:ID129452. doi: 10.1155/2012/129452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Gu H, Ma L, Ren Y, He W, Wang Y, Qiao Y. Exploration of the mechanism of pattern-specific treatments in coronary heart disease with network pharmacology approach. Comput Biol Med. 2014;51:198–204. doi: 10.1016/j.compbiomed.2014.05.003. [DOI] [PubMed] [Google Scholar]
- 30.Noble D. A modification of the hodgkin-huxley equations applicable to purkinje fibre action and pace-maker potentials. J Physiol. 1962;160(2):317–352. doi: 10.1113/jphysiol.1962.sp006849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Rodriguez B, Burrage K, Gavaghan D, Grau V, Kohl P, Noble D. The systems biology approach to drug development: application to toxicity assessment of cardiac drugs. Clin Pharmacol Ther. 2010;88(1):130–134. doi: 10.1038/clpt.2010.95. [DOI] [PubMed] [Google Scholar]
- 32.Bottino D, Penland RC, Stamps A, Traebert M, Dumotier B, Georgiva A et al. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart. Prog Biophys Mol Biol. 2006;90(1-3):414–443. doi: 10.1016/j.pbiomolbio.2005.06.006. [DOI] [PubMed] [Google Scholar]
- 33.Wang RR, Li N, Zhang YH, Ran YQ, Pu JL. The effects of paeoniflorin monomer of a Chinese herb on cardiac ion channels. Chin Med J. 2011;124(19):3105–3111. [PubMed] [Google Scholar]
- 34.Zhang GQ, Hao XM, Zhou PA, Wu CH. Effect of paeonol on L-type calcium channel in rat ventricular myocytes. Methods Find Exp Clin Pharmacol. 2003;25(4):281–285. doi: 10.1358/mf.2003.25.4.769676. [DOI] [PubMed] [Google Scholar]
- 35.Lee S, Noble P, Ma Y, Earm Y, Noble D. Potential antiarrhythmic effects of paeoniflorin and paeonol extracted from the paeoniaceae family.; The 36th international union of physiological sciences (IUPS); 2013 Jul 21-26; Birmingham, UK. London. 2013. p. 275. [Google Scholar]
- 36.Lee S. [A computer simulation study of the potential anti-arrhythmic properties of paeonol] Korean J Orient Physiol Pathol. 2015;29(4):305–312. Korean. [Google Scholar]
- 37.Noble P, Tasaki K, Gavaghan D, Miram G, Noble D. Simulation of the anti-arrhythmic properties of herbal remedics. The 36th International Union of Physiological Sciences; 2013; Birmingham. p. 358. [Google Scholar]
- 38.Hunter P, Coveney PV, de Bono, B, Diaz V, Fenner J, Frangi AF et al. A vision and strategy for the virtual physiological human in 2010 and beyond. Philos Trans A Math Phys Eng Sci. 2010;368(1920):2595–2614. doi: 10.1098/rsta.2010.0048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.de Bono, B, Hunter P. Integrating knowledge representation and quantitative modelling in physiology. Biotechnol J. 2012;7(8):958–972. doi: 10.1002/biot.201100304. [DOI] [PubMed] [Google Scholar]
- 40.Fang YC, Huang HC, Chen HH, Juan HF. TCMGeneDIT: a database for associated traditional Chinese medicine, gene and disease information using text mining. BMC Complement Altern Med. 2008;8(58):1–11. doi: 10.1186/1472-6882-8-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Zhang A, Sun H, Yang B, Wang X. Predicting new molecular targets for rhein using network pharmacology. BMC Syst Biol. 2012;6(20):1–8. doi: 10.1186/1752-0509-6-20. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 42.Fang Z, Lu B, Liu M, Zhang M, Yi Z, Wen C et al. Evaluating the pharmacological mechanism of Chinese medicine si-wu-tang through multi-level data integration. PLoS One. 2013;8(11):e72334. doi: 10.1371/journal.pone.0072334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Li B, Tao W, Zheng C, Shar PA, Huang C, Fu Y et al. Systems pharmacology-based approach for dissecting the addition and subtraction theory of traditional Chinese medicine: an example using xiao-chaihu-decoction and da-chaihu-decoction. Comput Biol Med. 2014;53:19–29. doi: 10.1016/j.compbiomed.2014.05.007. [DOI] [PubMed] [Google Scholar]
- 44.Zhang J, Li Y, Chen SS, Zhang L, Wang J, Yang Y et al. Systems pharmacology dissection of the anti-inflammatory mechanism for the medicinal herb Folium eriobotryae. Int J Mol Sci. 2015;16(2):2913–2941. doi: 10.3390/ijms16022913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.An L, Feng F. Network pharmacology-based antioxidant effect study of zhi-zi-da-huang decoction for alcoholic liver disease. Evid Based Complement Alternat Med. 2015;2015:ID492470. doi: 10.1155/2015/492470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Li Y, Zhang J, Zhang L, Chen X, Pan Y, Chen SS et al. Systems pharmacology to decipher the combinational anti-migraine effects of Tianshu formula. J Ethnopharmacol. 2015;S0378-8741(15):30056–30058. doi: 10.1016/j.jep.2015.07.043. [DOI] [PubMed] [Google Scholar]
- 47.Korea Institute of Science and Technology Evaluation and Planning. [Trend of technology and policy in Korean medicine] KISTEP; Seoul: 2010. 30. Korean. [Google Scholar]